EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic Features

Vandana Baloda, Raniah Al Amri, Pranav P Patwardhan, Sara A Monaghan, Erika M Moore, Bryan Rea, Miroslav Djokic, Nidhi Aggarwal, Grant C Bullock, Yen-Chun Liu, Svetlana Yatsenko, Nathanael G Bailey

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Vandana Baloda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, UPMC, Pittsburgh, Pennsylvania; Now with Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, University of Pittsburgh, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The criteria used to classify patients with myeloid neoplasms and monocytosis have changed in the fifth edition of the World Health Organization classification (WHO5) and the International Consensus Classification (ICC). Although both classifications have reduced the absolute monocyte count threshold for chronic myelomonocytic leukemia (CMML) to 0.5 × 109/L, the ICC has also introduced new morphologic criteria for CMML. We studied the effect of these changes on a large cohort of myeloid neoplasms with white blood cell count < 13 × 109/L and blasts

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelomonocytic, ChronicMyelodysplastic SyndromesHumansMaleFemaleAgedMiddle AgedMonocytesAged, 80 and overLeukocyte CountAdult

Stichwörter der Autor:innen

chronic myelomonocytic leukemiamyelodysplastic syndromesmyelodysplastic/myeloproliferative neoplasms

Autor:innen und Institutionen

  • Department of Pathology, UPMC, Pittsburgh, Pennsylvania; Now with Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Pathology, UPMC, Pittsburgh, Pennsylvania; Now with National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Department of Pathology, UPMC, Pittsburgh, Pennsylvania.
  • Department of Pathology, UPMC, Pittsburgh, Pennsylvania; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • NeoGenomics Laboratories, Fort Myers, Florida.
  • Department of Pathology, University of Iowa, Iowa City, Iowa.

Förderung

  • NCATS NIH HHS
  • University of Pittsburgh
  • National Institutes of Health

Zitieren

APA

Baloda, V., Al Amri, R., Patwardhan, P. P., Monaghan, S. A., Moore, E. M., Rea, B., Djokic, M., Aggarwal, N., Bullock, G. C., Liu, Y. C., Yatsenko, S., & Bailey, N. G. (2025). Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic Features. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100823

Vancouver

Baloda V, Al Amri R, Patwardhan PP, Monaghan SA, Moore EM, Rea B, et al. Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic Features. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100823

BibTeX
@article{Baloda2025,
  author = {Baloda, Vandana and Al Amri, Raniah and Patwardhan, Pranav P and Monaghan, Sara A and Moore, Erika M and Rea, Bryan and Djokic, Miroslav and Aggarwal, Nidhi and Bullock, Grant C and Liu, Yen-Chun and Yatsenko, Svetlana and Bailey, Nathanael G},
  title = {Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic Features},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100823}
}
Kostenlos starten →